Refined Read-out: The HUHRF1 Tandem-Tudor Domain Prefers Binding to Histone H3 Tails Containing K4me1 in the Context of H3K9me2/3
Overview
Affiliations
UHRF1 is an essential chromatin protein required for DNA methylation maintenance, mammalian development, and gene regulation. We investigated the Tandem-Tudor domain (TTD) of human UHRF1 that is known to bind H3K9me2/3 histones and is a major driver of UHRF1 localization in cells. We verified binding to H3K9me2/3 but unexpectedly discovered stronger binding to H3 peptides and mononucleosomes containing K9me2/3 with additional K4me1. We investigated the combined binding of TTD to H3K4me1-K9me2/3 versus H3K9me2/3 alone, engineered mutants with specific and differential changes of binding, and discovered a novel read-out mechanism for H3K4me1 in an H3K9me2/3 context that is based on the interaction of R207 with the H3K4me1 methyl group and on counting the H-bond capacity of H3K4. Individual TTD mutants showed up to a 10,000-fold preference for the double-modified peptides, suggesting that after a conformational change, WT TTD could exhibit similar effects. The frequent appearance of H3K4me1-K9me2 regions in human chromatin demonstrated in our TTD chromatin pull-down and ChIP-western blot data suggests that it has specific biological roles. Chromatin pull-down of TTD from HepG2 cells and full-length murine UHRF1 ChIP-seq data correlate with H3K4me1 profiles indicating that the H3K4me1-K9me2/3 interaction of TTD influences chromatin binding of full-length UHRF1. We demonstrate the H3K4me1-K9me2/3 specific binding of UHRF1-TTD to enhancers and promoters of cell-type-specific genes at the flanks of cell-type-specific transcription factor binding sites, and provided evidence supporting an H3K4me1-K9me2/3 dependent and TTD mediated downregulation of these genes by UHRF1. All these findings illustrate the important physiological function of UHRF1-TTD binding to H3K4me1-K9me2/3 double marks in a cellular context.
Phillips M, Malone K, Boyle B, Montgomery C, Kressy I, Joseph F J Med Chem. 2024; 67(10):8186-8200.
PMID: 38733345 PMC: 11149620. DOI: 10.1021/acs.jmedchem.4c00210.
Choudalakis M, Bashtrykov P, Jeltsch A Mob DNA. 2024; 15(1):6.
PMID: 38570859 PMC: 10988844. DOI: 10.1186/s13100-024-00315-y.
Song Y, Liu H, Xian Q, Gui C, Xu M, Zhou Y Oncol Lett. 2023; 26(6):542.
PMID: 38020304 PMC: 10660443. DOI: 10.3892/ol.2023.14129.
Choudalakis M, Kungulovski G, Mauser R, Bashtrykov P, Jeltsch A Protein Sci. 2023; 32(9):e4760.
PMID: 37593997 PMC: 10464304. DOI: 10.1002/pro.4760.